BLLN peer analysis
BillionToOne (BLLN) against its competitors: price, today's move, 1-year return and market value side by side.
BLLN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| FLGT Fulgent Genetics | $23.50 | 25.94% | 4.41% | $513.44M |
| GH Guardant Health | $150.00 | -2.24% | 59.17% | $20.59B |
| GRAL GRAIL | $122.47 | 2.80% | 50.59% | – |
| MYGN Myriad Genetics | $5.90 | -6.20% | -10.18% | $601.95M |
| NEO NeoGenomics | $16.84 | 2.12% | 61.55% | $2.13B |
| NTRA Natera | $311.20 | -14.45% | 56.72% | $52.43B |
| VCYT Veracyte | $24.20 | 0.83% | -47.57% | $1.93B |
| WGS GeneDx | $62.75 | -2.50% | -54.48% | $1.92B |
| BLLN BillionToOne | $115.26 | 2.55% | – | – |
- BLLN's peers: FLGT (Fulgent Genetics), GH (Guardant Health), GRAL (GRAIL), MYGN (Myriad Genetics), NEO (NeoGenomics), NTRA (Natera), VCYT (Veracyte), WGS (GeneDx).
Updated 2026-11-07 11:54 UTC